Gingival Anatomy

• Attached Gingiva Width: Greatest in maxillary incisors (3.5 – 4.5mm) and mandibular incisors (3.3 – 3.9mm)
• Least Width: Maxillary 1st premolars (1.9mm) and mandibular premolars (1.8mm)
• Biological Width: Connective tissue attachment (1.07mm) + Epithelial attachment (0.97mm) = ~2mm
• Oral Epithelium: 0.2 – 0.3mm thick, can be keratinized/parakeratinized

Junctional Epithelium (JE)

• Attached to enamel by hemidesmosomes
• Keratinocytes attached by desmosomes
• Internal basal lamina → tooth surface
• External basal lamina → gingival connective tissue

Cementum

• Maximum thickness: Apical third & furcation (150 – 200μm)
• Coronal half: 16 – 60μm
• Acellular cementum: First formed, covers cervical third
• Cellular cementum: Forms when tooth reaches occlusal plane

PERIODONTAL LIGAMENT (PDL) FIBERS

Principal Fibers (Type I Collagen)

1. Oblique fibers: Largest group, bear vertical forces
2. Alveolar crest fibers: Prevent tooth extrusion
3. Transseptal fibers: Only fibers reconstructed after bone destruction (considered gingival fibers)

Key Point

• Reticular fibers: Type III collagen

Systemic Antibiotics

• Most photosensitizing: Doxycycline
• Only one causing tooth discoloration: Minocycline

Local Drug Delivery

• Atridox: Doxycycline
• Arestin: Minocycline
• Elyzol: Metronidazole
• Periochip: Chlorhexidine
• Actisite: Tetracycline

Host Modulation

• SDD (Sub – antimicrobial Dose Doxycycline): Only FDA – approved host modulating agent

Alveolar Process

The alveolar process is a critical component of the dental anatomy, providing support for the teeth and playing a vital role in periodontal health. Understanding its structure and composition is essential for dental professionals in diagnosing and treating various dental conditions.

Components of the Alveolar Process

1. External Plate of Cortical Bone:

   • Description: The outer layer of the alveolar process is composed of cortical bone, which is dense and forms a protective outer shell.
   • Composition:
     • Formed by Haversian bone, which consists of organized structures called osteons.
     • Compacted bone lamellae contribute to the strength and stability of the alveolar process.

2. Alveolar Bone Proper:

   • Description: The inner socket wall of the alveolar process is known as the alveolar bone proper.
   • Radiographic Appearance:
     • It is seen as the lamina dura on radiographs, appearing as a radiopaque line surrounding the tooth roots.
   • Histological Features:
     • Contains a series of openings known as the cribriform plate.
     • These openings allow neurovascular bundles to connect the periodontal ligament with the central component of the alveolar bone, which is the cancellous bone.

3. Cancellous Bone:

   • Description: Located between the external cortical bone and the alveolar bone proper, cancellous bone consists of trabecular structures.
   • Function:
     • Acts as supporting alveolar bone, providing strength and flexibility to the alveolar process.
   • Interdental Septum:
     • The interdental septum consists of cancellous supporting bone enclosed within a compact border, providing stability between adjacent teeth.

Structural Characteristics

• Facial and Lingual Portions:
  • Most of the facial and lingual portions of the tooth socket are formed by compact bone alone, providing robust support for the teeth.
• Cancellous Bone Distribution:
  • Cancellous bone surrounds the lamina dura in specific areas:
    • Apical Areas: The region at the tip of the tooth root.
    • Apicolingual Areas: The area where the root meets the lingual surface.
    • Interradicular Areas: The space between the roots of multi-rooted teeth.

Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

1. Antibiotics:

   • Uses:
     • Used to treat bacterial infections associated with periodontal disease.
     • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
   • Mechanism:
     • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.

2. Antimicrobial Agents:

   • Chlorhexidine:
     • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
     • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
   • Tetracycline:
     • Uses: Can be used topically in periodontal pockets to reduce bacteria.
     • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.

3. Anti-Inflammatory Medications:

   • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
     • Uses: Used to manage pain and inflammation associated with periodontal disease.
     • Examples: Ibuprofen and naproxen.
   • Corticosteroids:
     • Uses: May be used in severe cases to reduce inflammation.
     • Mechanism: Suppress the immune response and reduce inflammation.

4. Local Delivery Systems:

   • Doxycycline Gel (Atridox):
     • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
     • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
   • Minocycline Microspheres (Arestin):
     • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
     • Mechanism: Releases minocycline over time to combat infection.

5. Regenerative Agents:

   • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
     • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
     • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.

6. Desensitizing Agents:

   • Fluoride Varnishes:
     • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
     • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

1. Management of Periodontal Disease:

   • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.

2. Adjunct to Non-Surgical Therapy:

   • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.

3. Surgical Interventions:

   • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.

4. Patient Compliance:

   • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues.

1. Elyzol

• Composition:
  • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
• Clinical Use:
  • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
  • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

• Composition:

  • Actisite consists of tetracycline-containing fibers.
  • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

• Clinical Use:

  • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

• Composition:

  • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

• Clinical Use:

  • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

• Composition:

  • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

• Clinical Use:

  • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

• Composition:

  • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

• Clinical Use:

  • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

• Composition:

  • Periochip is a biodegradable chip that contains chlorhexidine.

• Clinical Use:

  • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.

COPD

• Reid's index: Used in chronic bronchitis
• Emphysema features: ↓DLCO, weight loss, pneumothorax risk
• Chronic bronchitis: Polycythemia
• GOLD criteria: COPD severity assessment
• BODE index: Lung transplant evaluation

Sleep Apnea

Definition: Breathing pause ≥10 seconds during sleep

ASTHMA

Diagnosis & Pathophysiology

• Best diagnostic test: Demonstration of reversible obstruction
• Small airways involved
• Idiosyncratic asthma: Normal IgE levels
• Aspirin-sensitive asthma: Associated with nasal polyps

Key Points

• Charcot-Leyden crystals: Eosinophil granules
• Nebulizer droplet size: <2.5 μm
• Most severe attack indicator: Bradycardia
• Montelukast: NOT useful in acute bronchial asthma